Oleanolic acid inhibits the activity of the multidrug resistance protein ABCC1 (MRP1) but not of the ABCB1 (P-glycoprotein): Possible use in cancer chemotherapy

Cancer Letters

Volumn 248, Issue 1, 2007, Pages 147-152

  Braga, F ^a   Ayres Saraiva, D ^a   Gattass, C R ^a   Capella, M A M ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

ABCC1 (MRP1); Multidrug resistance; Natural products; Triterpene

Indexed keywords

GLYCOPROTEIN P; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN 1; OLEANOLIC ACID;

ANIMAL CELL; ARTICLE; CELL CULTURE; CELL LINE; CULTURE MEDIUM; DRUG EFFECT; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE; CELL SURVIVAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FLOW CYTOMETRY; GENE EXPRESSION; MULTIDRUG RESISTANCE-ASSOCIATED PROTEINS; OLEANOLIC ACID; P-GLYCOPROTEIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 33847298131     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2006.06.008     Document Type: Article

References (26)

1. Thomas H., and Coley H.M. Overcoming multidrug resistance in cancer: an update on the clinical strategy of inhibiting P-glycoprotein. Cancer Control 10 (2003) 159-165
2. Leonessa F., and Clarke R. ATP binding cassette transporters and drug resistance in breast cancer. Endocr. Relat. Cancer 10 (2003) 43-73
3. Han K., Kahng J., Kim M., Lim J., Kim Y., Cho B., Kim H.K., Min W.S., Kim C.C., Lee K.Y., Kim B.K., and Kang C.S. Expression of functional markers in acute nonlymphoblastic leukemia. Acta Haematol. 104 (2000) 174-180
4. Consoli U., Santonocito A., Stagno F., Fiumara P., Privitera A., Parisi G., Giustolisi G.M., Pavone B., Palumbo G.A., Di Raimondo F., Milone G., Guglielmo P., and Giustolisi R. Multidrug resistance mechanisms in chronic lymphocytic leukaemia. Br. J. Haematol. 116 (2002) 774-780
5. Leonard G.D., Fojo T., and Bates S.E. The role of ABC transporters in clinical practice. Oncologist 8 (2003) 411-424
6. Doubre H., Cesari D., Mairowitz A., Benac C., Chantot-Bastaraud S., Dagnon K., Anotine M., Danel D., Bernaudin J.F., and Fleury-Feith J. Multidrug resistance-associated protein (MRP1) is overexpressed in DNA aneuploid carcinomatous cells in non-small cell lung cancer (NSCLC). Int. J. Cancer 113 (2005) 568-574
7. Bodo A., Bakos E., Szeri F., Varadi A., and Sarkadi B. The role of multidrug transporters in drug availability, metabolism and toxicity. Toxicol. Lett. 140-141 (2003) 133-143
8. Modok S., Mellor H.R., and Callaghan R. Modulation of multidrug resistance efflux pump activity to overcome chemoresistance in cancer. Curr. Opin. Pharmacol. 6 (2006) 1-5
9. Fernandes J., Castilho R.O., da Costa M.R., Wagner-Souza K., Kaplan M.A.C., and Gattass C.R. Pentacyclic triterpenes from Chrysobalanaceae species: cytotoxicity on multidrug resistant and sensitive leukemia cell lines. Cancer Lett. 190 (2003) 165-169
10. Liu J. Pharmacology of oleanolic acid and ursolic acid. J. Ethnopharmacol. 48 (1995) 57-68
11. Liu J., Liu Y., Parkinson A., and Klaassen C.D. Effect of oleanolic acid on hepatic toxicant-activating and detoxifying systems in mice. J. Pharmacol. Exp. Ther. 275 (1995) 768-774
12. Ovesná Z., Vachálková A., Horváthová K., and Tóthová D. Pentacyclic triterpenoic acids: new chemoprotective compounds. Neoplasma 51 (2004) 327-333
13. Capella M.A., Orind M., Morales M.M., Rumjanek V.M., and Lopes A.G. Expression of functionally P-glycoprotein in Ma104 kidney cells. Z. Naturforsch. C54 (1999) 119-127
14. Capella L.S., Gefe M., Silva E.F., Morales M.M., Affonso-Mitidieri O., Lopes A.G., Rumjanek V.M., and Capella M.A.M. Reduced glutathione protect cells from ouabain toxicity. Biochim. Biophys. Acta 1526 (2001) 293-300
15. Mosmann T. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65 (1983) 55-63
16. Nascimento C.R., Braga F., Capella L.S., Santos O.R., Lopes A.G., and Capella M.A.M. Comparative study on the effects of cyclosporin A in renal cells in culture. Nephron Exp. Nephrol. 99 (2005) e77-e86
17. Courtois A., Payen L., Lagadic D., Guillouzo A., and Fardel O. Evidence for a multidrug resistance-associated protein 1 (MRP1)-related transport system in cultured rat liver biliary epithelial cells. Life Sci. 64 (1999) 763-774
18. Echevarria-Lima J., Kyle-Cezar F., Leite D.F.P., Capella L., Capella M.A.M., and Rumjanek V.M. Expression and activity of multidrug resistance protein 1 in a murine thymoma cell line. Immunology 114 (2005) 468-475
19. Jette L., Beaulieu E., Leclerc J.M., and Beliveau R. Cyclosporin A treatment induces overexpression of P-glycoprotein in the kidney and other tissues. Am. J. Physiol. 270 (1996) F756-F765
20. Krishna R., and Mayer L.D. Multidrug resistance (MDR) in cancer: Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs. Eur. J. Pharmac. Sci. 11 (2000) 265-283
21. Hsu H.Y., Yang J.J., and Lin C.C. Effects of oleanolic acid and ursolic acid on inhibiting tumor growth and enhancing the recovery of hematopoietic system postirradiation in mice. Cancer Lett. 111 (1997) 7-13
22. Kim Y.K., Yoon S.K., and Ryu S.Y. Cytotoxic triterpenes from stem bark of Physocarpus intermedius. Planta Med. 66 (2000) 485-486
23. Li J., Guo W.J., and Yang Q.Y. Effects of ursolic acid and oleanolic acid on human colon carcinoma cell line HCT15. World J. Gastroenterol. 8 (2002) 493-495
24. Singh G.B., Singh S., Bani S., Gupta B.D., and Banerjee S.K. Anti-inflammatory activity of oleanolic acid in rats and mice. J. Pharm. Pharmacol. 44 (1992) 456-458
25. Kapil A., and Sharma S. Effect of oleanolic acid on complement in adjuvant- and carrageenan-induced inflammation in rats. J. Pharm. Pharmacol. 47 (1995) 585-587
26. Rodriguez J.A., Astudillo L., and Schmeda-Hirschmann G. Oleanolic acid promotes healing of acetic acid-induced chronic gastric lesions in rats. Pharmacol. Res. 48 (2003) 291-294